<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Staphylococcus aureus &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/staphylococcus-aureus/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 12 Dec 2025 18:07:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Staphylococcus aureus &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Metallic Nanoparticles Combat Staphylococcus Infections: Review Insights</title>
		<link>https://bioengineer.org/metallic-nanoparticles-combat-staphylococcus-infections-review-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 12 Dec 2025 18:07:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antibacterial mechanisms]]></category>
		<category><![CDATA[antibiotic resistance]]></category>
		<category><![CDATA[Metallic nanoparticles]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Staphylococcus aureus]]></category>
		<guid isPermaLink="false">https://bioengineer.org/metallic-nanoparticles-combat-staphylococcus-infections-review-insights/</guid>

					<description><![CDATA[In recent years, the utilization of metallic nanoparticles in combating bacterial infections has gained significant attention within the scientific community. One of the most formidable pathogens, Staphylococcus aureus, poses a substantial threat to human health due to its ability to develop resistance against conventional antibiotics. In light of this challenge, a new study has emerged, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306868</post-id>	</item>
		<item>
		<title>Brian Peters part of multi-disciplinary team awarded $3.9 million to study mixed fungal-bacterial infections</title>
		<link>https://bioengineer.org/brian-peters-part-of-multi-disciplinary-team-awarded-3-9-million-to-study-mixed-fungal-bacterial-infections/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 14 Aug 2024 19:12:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Candida albicans]]></category>
		<category><![CDATA[infection mortality mechanisms]]></category>
		<category><![CDATA[mixed fungal-bacterial infections]]></category>
		<category><![CDATA[National Institute of Allergy and Infectious Diseases]]></category>
		<category><![CDATA[Staphylococcus aureus]]></category>
		<guid isPermaLink="false">https://bioengineer.org/brian-peters-part-of-multi-disciplinary-team-awarded-3-9-million-to-study-mixed-fungal-bacterial-infections/</guid>

					<description><![CDATA[Brian Peters, PhD, First Tennessee Endowed Chair of Excellence in Clinical Pharmacy and professor in the Department of Clinical Pharmacy and Translational Science at the UT Health Science Center, was recently awarded $3.9 million from the National Institute of Allergy and Infectious Diseases for a project aimed at unravelling intricate mysteries surrounding complex fungal-bacterial infections. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">231545</post-id>	</item>
	</channel>
</rss>
